Completed PHASE2 INTERVENTIONAL NCT00003308

Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma

A Phase II Trial of Radiosurgery for 1 to 3 Newly Diagnosed Brain Metastases From Renal Cell, Melanoma and Sarcoma

Sponsor: Eastern Cooperative Oncology Group

Conditions Kidney Cancer Melanoma (Skin) Metastatic Cancer Ovarian Cancer Sarcoma

Updated 6 times since 2017 Last updated: Jun 21, 2023 Started: Feb 2, 1999 Primary completion: Sep 30, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00003308, this PHASE2 trial focuses on Kidney Cancer and Melanoma (Skin) and remains completed. Sponsored by Eastern Cooperative Oncology Group, it has been updated 6 times since 1999, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jul 2023 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2023 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Feb 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Data source: Eastern Cooperative Oncology Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albuquerque, United States , Cleveland, United States , Des Moines, United States , Green Bay, United States , Hershey, United States , Kalamazoo, United States , Lima, Peru , Madison, United States , Papillion, United States , San Juan, Puerto Rico and 1 more location